Coign Capital Advisors
ABBV icon

Coign Capital Advisors’s AbbVie ABBV Stock Holding History

Coign Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$937K Buy
3,582
+18
+0.5% +$4.62K 0.42% 37
2026
Q2 		$897K Buy
3,564
+47
+1% +$10.1K 0.4% 41
2026
Q1 		$765K Buy
3,517
+41
+1% +$9.1K 0.4% 50
2025
Q4 		$794K Buy
3,476
+263
+8% +$59.9K 0.42% 46
2025
Q3 		$744K Buy
+3,213
New +$654K 0.41% 45

Other funds holding ABBV

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Coign Capital Advisors's ABBV Position: Q3 2026 in Review

Coign Capital Advisors increased its AbbVie (ABBV) stake by 0.51% in Q3 2026, buying an estimated $4.62K and bringing the position to 3,582 shares worth $937K. The position accounts for 0.42% of the portfolio, ranked #37.

Coign Capital Advisors first reported a position in ABBV in Q3 2025 and has held it in 5 quarters since. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Coign Capital Advisors held 3,582 shares of AbbVie worth $937K as of Q3 2026.
  • Coign Capital Advisors bought 18 AbbVie shares in Q3 2026, an estimated $4.62K.
  • AbbVie made up 0.42% of Coign Capital Advisors's portfolio in Q3 2026, its #37 holding.
  • Coign Capital Advisors first reported a position in AbbVie in Q3 2025 and has held it in 5 quarters since.
  • 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Coign Capital Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.